He presented to the ED with a temperature of 105.2 in status epilepticus.
An LP was recommended but not performed in the ED due to a policy of not doing LPs on patients with hardware in the CNS.
- History of pansensitive Proteus UTI with urinary retention [**2104-3-18**] - History Staph aureus bacteremia s/p 6 weeks of nafcillin initially planned to be completed in [**8-25**] - Line associated right internal jugular thrombophlebitis diagnosed in [**7-25**] with plan at that time for 3 months of AC - Known history of aspiration  Social History: - He lives with mother and is minimally functional since the accident per his mother "like a one month old baby".
- Tobacco: Denies - etOH: Denies - Illicits: Denies  Family History: Noncontributory  Physical Exam: GEN: Intubated and non-interactive, does not follow commands or respond to verbal stimuli, withdraws from painful stimuli, in NAD.
Reflexes are 0 at the patellar tendons and 1- at the biceps tendons.
Pertinent Results: Admission labs: [**2106-11-16**] 09:52PM [**Month/Day/Year 3143**] WBC-10.0 RBC-4.36* Hgb-12.0* Hct-37.0* MCV-85 MCH-27.6 MCHC-32.5 RDW-13.4 Plt Ct-157# [**2106-11-16**] 09:52PM [**Month/Day/Year 3143**] PT-14.4* PTT-96.1* INR(PT)-1.3* [**2106-11-16**] 09:52PM [**Month/Day/Year 3143**] Glucose-159* UreaN-9 Creat-0.7 Na-141 K-3.4 Cl-111* HCO3-19* AnGap-14 [**2106-11-16**] 09:52PM [**Month/Day/Year 3143**] ALT-70* AST-97* AlkPhos-193* TotBili-0.4 [**2106-11-16**] 09:52PM [**Month/Day/Year 3143**] Albumin-2.9* Calcium-7.3* Phos-1.6*# Mg-1.5*  CSF: [**2106-11-17**] 06:03AM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-0 Polys-0 Lymphs-45 Monos-55 [**2106-11-17**] 06:03AM CEREBROSPINAL FLUID (CSF) TotProt-19 Glucose-85  [**Month/Day/Year **], urine, sputum, and CSF cultures without growth.
CT HEAD W/O CONTRAST Study Date of [**2106-11-16**] 9:44 PM FINDINGS: As before, one ventriculostomy catheter via right transparietal approach, traverses the right lateral ventricle and septum pellucidum, to terminate in the dilated frontal [**Doctor Last Name 534**] of the left lateral ventricle.
The included paranasal sinuses are notable for circumferential mucosal thickening in the ethmoidal air cells bilaterally.
SHUNT SERIES AP & LAT SKULL, AP CHEST, AP ABDOMEN Study Date of [**2106-11-16**] 10:52 PM FINDINGS: Five radiographs of the head, neck, chest, and abdomen are obtained.
Ventriculoperitoneal and ventriculoatrial shunts are visualized, unchanged in their course when compared to CT images from [**2103-10-17**].
CHEST (PORTABLE AP) Study Date of [**2106-11-16**] 9:24 PM FINDINGS: Patient is status post ET tube placement.
Given the high position of the stomach underneath the ribcage, a safe window do not exist for percutaneous access and the study was canceled after discussion with the medical team.
Brief Hospital Course: 33 year old gentleman with a history of traumatic brain injury, seizure disorder, bactreremia with a VP shunt in place on long term antibiotics (cephalexin to [**3-/2107**]), and aspiration in the past who was admitted in status eplipticus with a high fever and possible pneumonia on CXR.
His LeVETiracetam was increased.
Initially treated empirically with CeftriaXONE 2 gm IV Q12H for CNS penetration, Levofloxacin 750 mg IV Q24H for CAP, Vancomycin 1000 mg IV Q 12H for Gram positives give history of long term nafcillin for MSSA bacteremia, and MetRONIDAZOLE (FLagyl) 500 mg IV Q8H aspiration (in combination with vancomycin and levofloxacin).
Dr.[**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **], the infectious disease specialist, who saw him before was contact[**Name (NI) **] regarding the course of cephalexin and stated that he will need to be on this medication till [**2107-3-17**].
Dalteparin (porcine) 15,000 unit/0.6 mL Syringe Sig: One (1) Subcutaneous once a day: Please take this medication daily till your primary care doctor tells you to stop it.
You will need to take Dalteparin shots till the Warfarin levels are appropriate.
Please keep all of the appointments with Dr.[**First Name (STitle) 31365**] as below so that she could monitor the levels carefully.
CONTINUE Cephalexin START Nystatin powder  Followup Instructions: Primary care doctor: Provider: [**Name10 (NameIs) **],[**First Name8 (NamePattern2) **] [**Hospital1 7975**] INTERNAL MEDICINE Phone:[**Telephone/Fax (1) 7976**] Date/Time:[**2106-12-6**] 9:30 Address: [**Hospital1 7977**], [**Location (un) 86**], [**Numeric Identifier 12201**] Please ask Dr.[**First Name (STitle) 31365**] to check your INR (warfarin's [**First Name (STitle) **] thinning levels).
If your INR level is at target, then you may be able to discontinue dalteparin.
